Ischemic heart disease

Reading File
Asking for Preferences
Finding Sources
Finding Sources
Searching Images

ischemic heart disease coronary artery atherosclerosis diagram

This diagnostic image is a coronary angiogram (left heart catheterization) showing the left coronary artery system. The visual focus is on the Left Anterior Descending (LAD) artery and the Left Circumflex (LCx) artery along with their diagonal and marginal branches. Multiple red arrows indicate areas of multifocal pathology, characterized by significant luminal narrowing and abrupt terminations of contrast opacification. Specifically, the image demonstrates diffuse atherosclerosis with severe segmentary stenoses (ranging from 60% to 90% in clinical context) and distal vessel occlusions. These findings are consistent with severe multivessel coronary artery disease (CAD), manifesting as compromised distal blood flow and reduced vessel diameter in both the LAD and LCx territories. This imaging is typically used in cardiology to evaluate ischemic heart disease and plan revascularization strategies.

This diagnostic image is a coronary angiogram (left heart catheterization) showing the left coronary artery system. The visual focus is on the Left Anterior Descending (LAD) artery and the Left Circumflex (LCx) artery along with their diagonal and marginal branches. Multiple red arrows indicate areas of multifocal pathology, characterized by significant luminal narrowing and abrupt terminations of contrast opacification. Specifically, the image demonstrates diffuse atherosclerosis with severe segmentary stenoses (ranging from 60% to 90% in clinical context) and distal vessel occlusions. These findings are consistent with severe multivessel coronary artery disease (CAD), manifesting as compromised distal blood flow and reduced vessel diameter in both the LAD and LCx territories. This imaging is typically used in cardiology to evaluate ischemic heart disease and plan revascularization strategies.

This diagnostic image consists of a large multiplanar reconstruction (MPR) and two smaller magnified views from a coronary computed tomography angiography (CCTA). The primary image demonstrates the spatial relationship between the aorta (Ao), pulmonary artery (PA), and the right coronary artery (RCA). The RCA is shown originating and coursing between the large circular aorta and the adjacent pulmonary artery. Pathological findings characteristic of atherosclerosis are highlighted within the RCA, specifically showing spotty calcification—indicated by focal, high-attenuation (bright) deposits within the vessel wall—and evidence of mild positive remodeling, characterized by a localized outward expansion of the arterial wall diameter at the site of the lesion. The magnified panels on the left provide detailed cross-sectional and longitudinal views of these atherosclerotic changes, emphasizing the eccentric plaque and calcified elements. This clinical image is used in cardiology to evaluate coronary artery anomalies and the morphological characteristics of coronary plaques in the context of ischemic heart disease.

This diagnostic image consists of a large multiplanar reconstruction (MPR) and two smaller magnified views from a coronary computed tomography angiography (CCTA). The primary image demonstrates the spatial relationship between the aorta (Ao), pulmonary artery (PA), and the right coronary artery (RCA). The RCA is shown originating and coursing between the large circular aorta and the adjacent pulmonary artery. Pathological findings characteristic of atherosclerosis are highlighted within the RCA, specifically showing spotty calcification—indicated by focal, high-attenuation (bright) deposits within the vessel wall—and evidence of mild positive remodeling, characterized by a localized outward expansion of the arterial wall diameter at the site of the lesion. The magnified panels on the left provide detailed cross-sectional and longitudinal views of these atherosclerotic changes, emphasizing the eccentric plaque and calcified elements. This clinical image is used in cardiology to evaluate coronary artery anomalies and the morphological characteristics of coronary plaques in the context of ischemic heart disease.

The visual content is composed of two educational panels focused on coronary artery disease (CAD) and intravascular ultrasound (IVUS) technology. Panel (a) is an anatomical diagram of a human heart illustrating the coronary circulation. It highlights the Right Coronary Artery (RCA) and the Left Anterior Descending (LAD) artery. Two inset circular cross-sections demonstrate the pathophysiology of atherosclerosis: one shows a healthy, patent vessel with a smooth lumen, while the other depicts a diseased vessel with yellow atherosclerotic plaque causing significant luminal narrowing (stenosis). The large vessels, including the aorta (red) and pulmonary artery (blue), provide anatomical context. Panel (b) is a clinical photograph of an IVUS acquisition system. The medical equipment is a mobile workstation featuring a high-resolution monitor for real-time cross-sectional vessel imaging, a keyboard/input console, and a wheeled base. This dual-panel image illustrates the clinical application of imaging technology in diagnosing and managing coronary atherosclerosis and guiding percutaneous coronary interventions (PCI).

The visual content is composed of two educational panels focused on coronary artery disease (CAD) and intravascular ultrasound (IVUS) technology. Panel (a) is an anatomical diagram of a human heart illustrating the coronary circulation. It highlights the Right Coronary Artery (RCA) and the Left Anterior Descending (LAD) artery. Two inset circular cross-sections demonstrate the pathophysiology of atherosclerosis: one shows a healthy, patent vessel with a smooth lumen, while the other depicts a diseased vessel with yellow atherosclerotic plaque causing significant luminal narrowing (stenosis). The large vessels, including the aorta (red) and pulmonary artery (blue), provide anatomical context. Panel (b) is a clinical photograph of an IVUS acquisition system. The medical equipment is a mobile workstation featuring a high-resolution monitor for real-time cross-sectional vessel imaging, a keyboard/input console, and a wheeled base. This dual-panel image illustrates the clinical application of imaging technology in diagnosing and managing coronary atherosclerosis and guiding percutaneous coronary interventions (PCI).

Reading File
Reading File
Finding Sources
Reading File
Reading File
Reading File
Finding Sources
Loading Image
I have all the content needed. Here is a comprehensive quick-summary of ischemic heart disease:

Ischemic Heart Disease (IHD) - Clinical Summary

Definition

IHD is a broad term for several syndromes caused by an imbalance between cardiac blood supply and myocardial oxygen/nutritional demand. It is the leading cause of mortality in high-income nations, accounting for ~7.5 million deaths annually worldwide. About 800,000 Americans experience an MI each year.
  • In >90% of cases, IHD results from obstructive atherosclerotic coronary artery disease (CAD).
  • The remaining cases involve increased demand (tachycardia, hypertension), reduced blood volume (shock), reduced oxygenation (pneumonia, CHF), or reduced oxygen-carrying capacity (anemia, CO poisoning).
(Robbins & Kumar Basic Pathology)

Clinical Syndromes

SyndromeKey Feature
Stable anginaChest pain predictably at exertion; >70% stenosis ("critical stenosis")
Unstable anginaChest pain at rest or with less exertion; plaque disruption + non-occlusive thrombus
Vasospastic (Prinzmetal) anginaCoronary spasm, often at rest; ST elevation that resolves
NSTEMITroponin elevation, no ST elevation; subendocardial infarction
STEMIFull-thickness (transmural) infarction; ST elevation + new LBBB
Sudden cardiac death (SCD)Ventricular fibrillation from acute ischemia
Chronic IHD / ischemic cardiomyopathyProgressive pump failure from cumulative ischemic insults
The term acute coronary syndrome (ACS) covers unstable angina, NSTEMI, and STEMI.

Pathophysiology

Two key mechanisms:
  1. Fixed atherosclerotic stenosis - plaques gradually narrow the lumen. Lesions <70% are typically asymptomatic. >70% causes stable angina. >90% may cause rest pain. If slow progression occurs, collaterals can form and protect against infarction.
  2. Acute plaque change (most ACS) - rupture or erosion of a plaque exposes thrombogenic material, triggering rapid thrombus formation:
    • Plaque disruption → platelet adhesion → thromboxane A2, ADP, serotonin release → platelet aggregation + vasospasm
    • Tissue factor activation → coagulation cascade → occlusive thrombus
    • Angiography within 4 hours of MI shows thrombotic occlusion in ~90% of cases
Myocardial response to ischemia:
  • Aerobic metabolism stops within seconds → ATP drops, lactate accumulates
  • Contractility lost within minutes
  • Irreversible necrosis after 20-40 minutes of sustained ischemia
  • After 4-6 hours: gross infarct visible; peak cell death at 12-24 hours
Vasoconstriction worsens ischemia and is triggered by adrenergic agonists, platelet products, endothelial dysfunction (↓ nitric oxide, ↑ endothelin), and perivascular inflammation.
(Robbins & Kumar Basic Pathology)

Diagnosis

TestKey Finding
ECGST elevation (STEMI), ST depression/T-wave inversion (NSTEMI/UA), new Q waves (old MI)
High-sensitivity troponin (hs-cTnI/T)Gold standard biomarker; rises within 1-3 h, peaks 12-24 h, returns to baseline in 7-10 days
CK-MBRises in 4-8 h, returns to normal in 48-72 h; useful for reinfarction detection
EchocardiographyRegional wall motion abnormalities; assesses LV function
Coronary angiographyDefinitive anatomy; guide to PCI or CABG
CT coronary angiographyNon-invasive assessment of stenosis, plaque burden
The Fourth Universal Definition of MI classifies troponin-positive patients into:
  • Type I MI - spontaneous from plaque rupture (includes STEMI and NSTEMI)
  • Type II MI - supply-demand mismatch (e.g., tachyarrhythmia, anemia)
  • Myocardial injury - troponin elevation without ischemic mechanism
(Fuster and Hurst's The Heart, 15th Ed.)

Risk Factors

  • Modifiable: Smoking, hypertension, dyslipidemia, diabetes mellitus, obesity, sedentary lifestyle
  • Non-modifiable: Age, male sex, family history

Management

Acute ACS (STEMI/NSTEMI)

DrugRole
Aspirin (162-325 mg load, then 81 mg daily)Antiplatelet; immediate, indefinite
P2Y12 inhibitor (clopidogrel, ticagrelor, prasugrel)Dual antiplatelet therapy (DAPT)
Anticoagulant (UFH, LMWH, fondaparinux)All ACS patients unless active bleeding
Beta-blocker (metoprolol 25-50 mg PO)Within 24 h; reduces ischemia and MI risk
Nitrates (sublingual / IV)Symptomatic relief; avoid with PDE-5 inhibitors
Statin (atorvastatin 40-80 mg)Immediately; indefinitely
ACE inhibitor/ARBPost-MI, especially with reduced EF
Reperfusion:
  • STEMI: Primary PCI (goal door-to-balloon <90 min) is preferred; thrombolysis if PCI unavailable within 120 min
  • High-risk NSTEMI: Early invasive strategy (PCI within 24-48 h); high-sensitivity troponin guides risk stratification

Stable Angina (Chronic IHD)

  • Beta-blockers - first-line anti-anginal
  • Long-acting nitrates - symptom control (nitrate-free interval to prevent tolerance)
  • Calcium channel blockers (diltiazem, verapamil) - alternative or add-on
  • Revascularization (PCI or CABG) - for refractory angina, left main disease, or 3-vessel disease with reduced EF
(Goldman-Cecil Medicine; Goodman & Gilman's Pharmacology)

Complications of MI

ComplicationTiming
Ventricular fibrillationFirst hours ("electrical storm")
Pump failure / cardiogenic shockDays 1-3
Papillary muscle rupture (mitral regurgitation)Days 2-7
Free wall rupture / tamponadeDays 3-7
Ventricular septal defect (VSD)Days 3-7
Pericarditis (Dressler syndrome)Weeks to months
LV aneurysmWeeks (anterior MI, LAD territory)
Mural thrombus / embolismWeeks

Coronary Artery Anatomy Affected

Significant plaques preferentially occur in the proximal LAD and LCX and along the entire RCA. The LAD supplies the anterior wall and anterior septum; its occlusion (most common) causes anterior STEMI. The RCA supplies the inferior wall and the SA/AV nodes (inferior MI with bradycardia). The LCX supplies the lateral wall.
Coronary angiogram showing multivessel CAD with severe stenoses and occlusions in LAD and LCx territories

Sources: Robbins & Kumar Basic Pathology; Braunwald's Heart Disease; Goldman-Cecil Medicine; Fuster & Hurst's The Heart, 15th Ed.; Goodman & Gilman's Pharmacology.
This is a shared conversation. Sign in to Orris to start your own chat.